Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 281

1.

[Osteoimmunology-IMMUNOBONE : Regulation of bone by inflammation].

Rauner M, Buttgereit F, Distler J, Garbe AI, Herrmann M, Hofbauer L, Hoffmann M, Jessberger R, Kornak U, Krönke G, Mundlos S, Spies C, Tuckermann J, Zwerina J.

Z Rheumatol. 2018 May;77(Suppl 1):12-15. doi: 10.1007/s00393-018-0455-0. Review. German. No abstract available.

PMID:
29691689
2.

Role of 11β-HSD type 1 in abnormal HPA axis activity during immune-mediated arthritis.

Sattler J, Tu J, Stoner S, Li J, Buttgereit F, Seibel MJ, Zhou H, Cooper MS.

Endocr Connect. 2018 Feb;7(2):385-394. doi: 10.1530/EC-17-0361. Epub 2018 Jan 31.

3.

In silico methods - Computational alternatives to animal testing.

Lang A, Volkamer A, Behm L, Röblitz S, Ehrig R, Schneider M, Geris L, Wichard J, Buttgereit F.

ALTEX. 2018;35(1):124-126. doi: 10.14573/altex.1712031. No abstract available.

4.

Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.

Hartman L, Rasch LA, Klausch T, Bijlsma HWJ, Christensen R, Smulders YM, Ralston SH, Buttgereit F, Cutolo M, Da Silva JAP, Opris D, Rovenský J, Szamosi S, Middelink LM, Lems WF, Boers M.

Trials. 2018 Jan 25;19(1):67. doi: 10.1186/s13063-017-2396-3.

5.

Efficacy and safety of selective glucocorticoid receptor modulators in comparison to glucocorticoids in arthritis, a systematic review.

Safy M, de Hair MJH, Jacobs JWG, Buttgereit F, Kraan MC, van Laar JM.

PLoS One. 2017 Dec 21;12(12):e0188810. doi: 10.1371/journal.pone.0188810. eCollection 2017. Review.

6.

Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.

Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.

Rheumatol Int. 2018 Apr;38(4):569-577. doi: 10.1007/s00296-017-3874-3. Epub 2017 Nov 9.

PMID:
29124397
7.

Low-dose glucocorticoids in rheumatoid arthritis: blurring the line between therapeutic dose and substitution therapy?

Palmowski Y, Boers M, Buttgereit F.

Arthritis Care Res (Hoboken). 2017 Oct 26. doi: 10.1002/acr.23452. [Epub ahead of print]

PMID:
29073333
8.

Unraveling the role of hypoxia-inducible factor (HIF)-1α and HIF-2α in the adaption process of human microvascular endothelial cells (HMEC-1) to hypoxia: Redundant HIF-dependent regulation of macrophage migration inhibitory factor.

Hahne M, Schumann P, Mursell M, Strehl C, Hoff P, Buttgereit F, Gaber T.

Microvasc Res. 2018 Mar;116:34-44. doi: 10.1016/j.mvr.2017.09.004. Epub 2017 Oct 6.

PMID:
28993199
9.

Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B.

Nat Rev Rheumatol. 2017 Oct;13(10):578-592. doi: 10.1038/nrrheum.2017.142. Epub 2017 Sep 14. Review.

10.

The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.

Mackie SL, Twohig H, Neill LM, Harrison E, Shea B, Black RJ, Kermani TA, Merkel PA, Mallen CD, Buttgereit F, Mukhtyar C, Simon LS, Hill CL; OMERACT PMR Working Group.

J Rheumatol. 2017 Oct;44(10):1515-1521. doi: 10.3899/jrheum.161109. Epub 2017 Aug 1.

PMID:
28765246
11.

Will we ever have better glucocorticoids?

Buttgereit F, Bijlsma JWJ, Strehl C.

Clin Immunol. 2018 Jan;186:64-66. doi: 10.1016/j.clim.2017.07.023. Epub 2017 Jul 27.

PMID:
28757452
12.

Inflammation Is an Important Covariate for the Crosstalk of Sleep and the HPA Axis in Rheumatoid Arthritis.

Straub RH, Detert J, Dziurla R, Fietze I, Loeschmann PA, Burmester GR, Buttgereit F.

Neuroimmunomodulation. 2017;24(1):11-20. doi: 10.1159/000475714. Epub 2017 May 24.

PMID:
28535535
13.

Glucocorticoids in rheumatoid arthritis: the picture is shaping up.

Buttgereit F, Bijlsma JW.

Ann Rheum Dis. 2017 Nov;76(11):1785-1787. doi: 10.1136/annrheumdis-2017-211187. Epub 2017 May 4. No abstract available.

PMID:
28473424
14.

Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study.

Cutolo M, Hopp M, Liebscher S, Dasgupta B, Buttgereit F.

RMD Open. 2017 Mar 17;3(1):e000426. doi: 10.1136/rmdopen-2016-000426. eCollection 2017.

15.

Metabolic regulation of inflammation.

Gaber T, Strehl C, Buttgereit F.

Nat Rev Rheumatol. 2017 May;13(5):267-279. doi: 10.1038/nrrheum.2017.37. Epub 2017 Mar 23. Review.

PMID:
28331208
16.

A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients.

Hoff P, Gaber T, Strehl C, Jakstadt M, Hoff H, Schmidt-Bleek K, Lang A, Röhner E, Huscher D, Matziolis G, Burmester GR, Schmidmaier G, Perka C, Duda GN, Buttgereit F.

Int J Mol Sci. 2017 Mar 8;18(3). pii: E583. doi: 10.3390/ijms18030583.

17.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Smolen JS, Landewé R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M, Nam J, Ramiro S, Voshaar M, van Vollenhoven R, Aletaha D, Aringer M, Boers M, Buckley CD, Buttgereit F, Bykerk V, Cardiel M, Combe B, Cutolo M, van Eijk-Hustings Y, Emery P, Finckh A, Gabay C, Gomez-Reino J, Gossec L, Gottenberg JE, Hazes JMW, Huizinga T, Jani M, Karateev D, Kouloumas M, Kvien T, Li Z, Mariette X, McInnes I, Mysler E, Nash P, Pavelka K, Poór G, Richez C, van Riel P, Rubbert-Roth A, Saag K, da Silva J, Stamm T, Takeuchi T, Westhovens R, de Wit M, van der Heijde D.

Ann Rheum Dis. 2017 Jun;76(6):960-977. doi: 10.1136/annrheumdis-2016-210715. Epub 2017 Mar 6. Review.

PMID:
28264816
18.

Differences in biomarkers of cartilage matrix turnover and their changes over 2 years in adolescent and adult volleyball athletes.

Boeth H, MacMahon A, Poole AR, Buttgereit F, Önnerfjord P, Lorenzo P, Klint C, Pramhed A, Duda GN.

J Exp Orthop. 2017 Dec;4(1):7. doi: 10.1186/s40634-017-0081-9. Epub 2017 Feb 23.

19.

Plant-derived pectin nanocoatings to prevent inflammatory cellular response of osteoblasts following Porphyromonas gingivalis infection.

Meresta A, Folkert J, Gaber T, Miksch K, Buttgereit F, Detert J, Pischon N, Gurzawska K.

Int J Nanomedicine. 2017 Jan 12;12:433-445. doi: 10.2147/IJN.S113740. eCollection 2017.

20.

Nanocoating with plant-derived pectins activates osteoblast response in vitro.

Folkert J, Meresta A, Gaber T, Miksch K, Buttgereit F, Detert J, Pischon N, Gurzawska K.

Int J Nanomedicine. 2016 Dec 29;12:239-249. doi: 10.2147/IJN.S99020. eCollection 2017.

21.

Quantifying cutaneous adverse effects of systemic glucocorticoids in patients with rheumatoid arthritis: a cross-sectional cohort study.

Amann J, Wessels AM, Breitenfeldt F, Huscher D, Bijlsma JWJ, Jacobs JWG, Buttgereit F.

Clin Exp Rheumatol. 2017 May-Jun;35(3):471-476. Epub 2017 Jan 15.

PMID:
28094753
22.

Glucocorticoid-targeted therapies for the treatment of rheumatoid arthritis.

Strehl C, van der Goes MC, Bijlsma JW, Jacobs JW, Buttgereit F.

Expert Opin Investig Drugs. 2017 Feb;26(2):187-195. doi: 10.1080/13543784.2017.1276562. Epub 2017 Jan 3. Review.

PMID:
28043173
23.

"Official View" on Glucocorticoids in Rheumatoid Arthritis: A Systematic Review of International Guidelines and Consensus Statements.

Palmowski Y, Buttgereit T, Dejaco C, Bijlsma JW, Matteson EL, Voshaar M, Boers M, Buttgereit F.

Arthritis Care Res (Hoboken). 2017 Aug;69(8):1134-1141. doi: 10.1002/acr.23185. Epub 2017 Jul 10. Review. Erratum in: Arthritis Care Res (Hoboken). 2018 Jan;70(1):144.

PMID:
28029750
24.

Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humans.

Strehl C, Maurizi L, Gaber T, Hoff P, Broschard T, Poole AR, Hofmann H, Buttgereit F.

Int J Nanomedicine. 2016 Nov 8;11:5883-5896. eCollection 2016.

25.

Adverse events of glucocorticoids during treatment of rheumatoid arthritis: lessons from cohort and registry studies.

W J Bijlsma J, Buttgereit F.

Rheumatology (Oxford). 2016 Dec;55(suppl 2):ii3-ii5. Review.

PMID:
27856654
26.

Rheumatology Workforce Planning in Western Countries: A Systematic Literature Review.

Dejaco C, Lackner A, Buttgereit F, Matteson EL, Narath M, Sprenger M.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1874-1882. doi: 10.1002/acr.22894. Epub 2016 Oct 28. Review.

27.

Can adverse effects of glucocorticoid therapy be prevented and treated?

van der Goes MC, Strehl C, Buttgereit F, Bijlsma JW, Jacobs JW.

Expert Opin Pharmacother. 2016 Nov;17(16):2129-2133. Epub 2016 Sep 20. No abstract available.

PMID:
27590884
28.

Immunological characterization of the early human fracture hematoma.

Hoff P, Gaber T, Strehl C, Schmidt-Bleek K, Lang A, Huscher D, Burmester GR, Schmidmaier G, Perka C, Duda GN, Buttgereit F.

Immunol Res. 2016 Dec;64(5-6):1195-1206.

PMID:
27629117
29.

[Diagnostics and treatment of polymyalgia rheumatica].

Dejaco C, Matteson EL, Buttgereit F.

Z Rheumatol. 2016 Sep;75(7):687-700. doi: 10.1007/s00393-016-0105-3. Review. German.

PMID:
27488446
30.

The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease.

Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B.

Rheumatology (Oxford). 2017 Apr 1;56(4):506-515. doi: 10.1093/rheumatology/kew273. Review.

PMID:
27481272
31.

Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis.

Miloslavsky EM, Naden RP, Bijlsma JW, Brogan PA, Brown ES, Brunetta P, Buttgereit F, Choi HK, DiCaire JF, Gelfand JM, Heaney LG, Lightstone L, Lu N, Murrell DF, Petri M, Rosenbaum JT, Saag KS, Urowitz MB, Winthrop KL, Stone JH.

Ann Rheum Dis. 2017 Mar;76(3):543-546. doi: 10.1136/annrheumdis-2016-210002. Epub 2016 Jul 29.

32.

Sustained Increase of 25-Hydroxyvitamin D Levels in Healthy Young Women during Wintertime after Three Suberythemal UV Irradiations-The MUVY Pilot Study.

Biersack MG, Hajdukiewicz M, Uebelhack R, Franke L, Piazena H, Klaus P, Höhne-Zimmer V, Braun T, Buttgereit F, Burmester GR, Detert J.

PLoS One. 2016 Jul 19;11(7):e0159040. doi: 10.1371/journal.pone.0159040. eCollection 2016. Erratum in: PLoS One. 2017 Jan 3;12 (1):e0169709.

33.

Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid arthritis.

Detert J, Dziurla R, Hoff P, Gaber T, Klaus P, Bastian H, Braun T, Schellmann S, Penzel T, Fietze I, Loeschmann PA, Jaehnig P, Straub RH, Burmester GR, Buttgereit F.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):848-856. Epub 2016 Jun 22.

PMID:
27385076
34.

Rheumatoid arthritis: Glucocorticoid therapy and body composition.

Buttgereit F, Burmester GR.

Nat Rev Rheumatol. 2016 Aug;12(8):444-5. doi: 10.1038/nrrheum.2016.114. Epub 2016 Jul 7. No abstract available.

PMID:
27383915
35.

[Long-term glucocorticoid therapy : Is there a safe dosage?].

Strehl C, Buttgereit F.

Internist (Berl). 2016 Sep;57(9):934-9. doi: 10.1007/s00108-016-0098-7. Review. German.

PMID:
27351788
36.

Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.

Buttgereit F, Dejaco C, Matteson EL, Dasgupta B.

JAMA. 2016 Jun 14;315(22):2442-58. doi: 10.1001/jama.2016.5444. Review.

PMID:
27299619
37.

Transgenic Disruption of Glucocorticoid Signaling in Osteoblasts Attenuates Joint Inflammation in Collagen Antibody-Induced Arthritis.

Tu J, Zhang Y, Kim S, Wiebe E, Spies CM, Buttgereit F, Cooper MS, Seibel MJ, Zhou H.

Am J Pathol. 2016 May;186(5):1293-301. doi: 10.1016/j.ajpath.2015.12.025. Epub 2016 Mar 14.

PMID:
26988651
38.

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.

Strehl C, Bijlsma JW, de Wit M, Boers M, Caeyers N, Cutolo M, Dasgupta B, Dixon WG, Geenen R, Huizinga TW, Kent A, de Thurah AL, Listing J, Mariette X, Ray DW, Scherer HU, Seror R, Spies CM, Tarp S, Wiek D, Winthrop KL, Buttgereit F.

Ann Rheum Dis. 2016 Jun;75(6):952-7. doi: 10.1136/annrheumdis-2015-208916. Epub 2016 Mar 1. Review.

PMID:
26933146
39.

Increased Periodontal Attachment Loss in Patients With Systemic Sclerosis.

Pischon N, Hoedke D, Kurth S, Lee P, Dommisch H, Steinbrecher A, Pischon T, Burmester GR, Buttgereit F, Detert J, Riemekasten G.

J Periodontol. 2016 Jul;87(7):763-71. doi: 10.1902/jop.2016.150475. Epub 2016 Feb 28.

PMID:
26923473
40.

Effects of PVA-coated nanoparticles on human T helper cell activity.

Strehl C, Schellmann S, Maurizi L, Hofmann-Amtenbrink M, Häupl T, Hofmann H, Buttgereit F, Gaber T.

Toxicol Lett. 2016 Mar 14;245:52-8. doi: 10.1016/j.toxlet.2016.01.003. Epub 2016 Jan 13.

PMID:
26774940
41.

Disentangling the effects of tocilizumab on neutrophil survival and function.

Gaber T, Hahne M, Strehl C, Hoff P, Dörffel Y, Feist E, Burmester GR, Buttgereit F.

Immunol Res. 2016 Jun;64(3):665-76. doi: 10.1007/s12026-015-8770-x.

PMID:
26721805
42.

Imaging: Whole-body MRI undresses polymyalgia rheumatica.

Buttgereit F, Matteson EL.

Nat Rev Rheumatol. 2016 Mar;12(3):140-1. doi: 10.1038/nrrheum.2015.163. Epub 2015 Dec 3. No abstract available.

PMID:
26633289
43.

Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.

Matteson EL, Buttgereit F, Dejaco C, Dasgupta B.

Rheum Dis Clin North Am. 2016 Feb;42(1):75-90, viii. doi: 10.1016/j.rdc.2015.08.009. Review.

PMID:
26611552
44.

Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid Arthritis.

Buttgereit F, Kent JD, Holt RJ, Grahn AY, Rice P, Alten R, Yazici Y.

Bull Hosp Jt Dis (2013). 2015 Jul;73(3):168-77.

45.

Delayed-release prednisone improves fatigue and health-related quality of life: findings from the CAPRA-2 double-blind randomised study in rheumatoid arthritis.

Alten R, Grahn A, Holt RJ, Rice P, Buttgereit F.

RMD Open. 2015 Aug 13;1(1):e000134. doi: 10.1136/rmdopen-2015-000134. eCollection 2015.

46.

Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?

Buttgereit F, Burmester GR, Bijlsma JW.

RMD Open. 2015 Feb 18;1(1):e000027. doi: 10.1136/rmdopen-2014-000027. eCollection 2015.

47.

Glucocorticoids in the treatment of rheumatoid arthritis.

Bijlsma JW, Jacobs JW, Buttgereit F.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S34-6. Epub 2015 Oct 12. Review.

PMID:
26457916
48.

Novel glucocorticoids: where are we now and where do we want to go?

Buttgereit F, Spies CM, Bijlsma JW.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S29-33. Epub 2015 Oct 12. Review.

PMID:
26457359
49.

2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K, Bianconi L, Buttgereit F, Carsons S, Ching D, Cid M, Cimmino M, Diamantopoulos A, Docken W, Duftner C, Fashanu B, Gilbert K, Hildreth P, Hollywood J, Jayne D, Lima M, Maharaj A, Mallen C, Martinez-Taboada V, Maz M, Merry S, Miller J, Mori S, Neill L, Nordborg E, Nott J, Padbury H, Pease C, Salvarani C, Schirmer M, Schmidt W, Spiera R, Tronnier D, Wagner A, Whitlock M, Matteson EL, Dasgupta B; European League Against Rheumatism; American College of Rheumatology.

Ann Rheum Dis. 2015 Oct;74(10):1799-807. doi: 10.1136/annrheumdis-2015-207492.

50.

2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Dejaco C, Singh YP, Perel P, Hutchings A, Camellino D, Mackie S, Abril A, Bachta A, Balint P, Barraclough K, Bianconi L, Buttgereit F, Carsons S, Ching D, Cid M, Cimmino M, Diamantopoulos A, Docken W, Duftner C, Fashanu B, Gilbert K, Hildreth P, Hollywood J, Jayne D, Lima M, Maharaj A, Mallen C, Martinez-Taboada V, Maz M, Merry S, Miller J, Mori S, Neill L, Nordborg E, Nott J, Padbury H, Pease C, Salvarani C, Schirmer M, Schmidt W, Spiera R, Tronnier D, Wagner A, Whitlock M, Matteson EL, Dasgupta B; European League Against Rheumatism; American College of Rheumatology.

Arthritis Rheumatol. 2015 Oct;67(10):2569-80. doi: 10.1002/art.39333.

Supplemental Content

Loading ...
Support Center